Earnings calendar/LYEL
Lyell Immunopharma, Inc. (LYEL)
Next report date and post-earnings actuals — standardized metrics from the filed statements. No analyst estimates, no narrative, no price targets.
Pre-earnings
The next report date (from the company's filing cadence) and how the business has been running.
Next report
Nov 10, 2026
Expected from filing cadence
EPS target
$-2.06
Estimates not sourced
Revenue target
$3,833
Estimates not sourced
Trailing EPS (avg 4Q)
$-3.21
Beat rate last 4: 50%
Latest EPS YoY
+33.6%
vs 2025-08-12
Latest revenue YoY
-50.0%
How results look so far
Trailing revenue (avg 4Q)
$6,750
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 6, 2026
EPS miss
EPS actual / est
$-1.92 / $-1.90
-1.1%
Revenue actual / est
$4,000 / $3,625
+10.3%
Result
Below target
EPS vs prior estimate, when one exists
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/10/2026upcoming | $-2.06 | Pending | — | $3,833 | Pending | — |
| 8/6/2026 | $-1.90 | $-1.92 | -1.1% | $3,625 | $4,000 | +10.3% |
| 5/12/2026upcoming | $-2.37 | Pending | — | $5,500 | Pending | — |
| 5/6/2026 | $-2.78 | $-1.10 | +60.4% | $3,000 | $2,000 | -33.3% |
| 3/12/2026 | $-2.15 | $-7.68 | -257.2% | $15,250 | $6,000 | -60.7% |
| 3/10/2026upcoming | $-2.23 | Pending | — | $20,330 | Pending | — |
| 11/12/2025 | $-2.81 | $-2.13 | +24.2% | $5,000 | $15,000 | +200.0% |
| 8/12/2025 | $-3.80 | $-2.89 | +23.9% | $4,000 | $8,000 | +100.0% |
| 5/13/2025 | $-3.60 | $-3.60 | 0.0% | $7,000 | $7,000 | 0.0% |
| 3/11/2025 | $-3.40 | $-14.40 | -323.5% | — | $11,000 | — |
| 11/7/2024 | $-0.20 | $-3.40 | -1600.0% | — | $34,000 | — |
| 8/7/2024 | $-4.00 | $-3.60 | +10.0% | $3,250 | $13,000 | +300.0% |
| 5/6/2024 | $-4.00 | $-4.80 | -20.0% | $1,000 | $3,000 | +200.0% |
| 2/28/2024 | $-4.20 | $-4.00 | +4.8% | $3,250 | $13,000 | +300.0% |
| 11/7/2023 | $-4.84 | $-4.00 | +17.4% | $6,250 | $25,000 | +300.0% |
| 8/8/2023 | $-5.25 | $-5.20 | +1.0% | $18,000 | $27,000 | +50.0% |
| 5/4/2023 | $-0.31 | $-0.23 | +25.8% | $-17,500 | $65,000 | +471.4% |
| 2/28/2023 | $-0.31 | $-0.03 | +90.3% | $16.1M | $48.4M | +200.0% |
| 11/8/2022 | $-0.34 | $-0.28 | +17.6% | $1.8M | $3,000 | -99.8% |
| 8/4/2022 | $-6.20 | $-0.15 | +97.6% | $17.9M | $35.7M | +100.0% |
Need LYEL data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.